IFPx pitched on the Main Stage at the Advamed Medical Device Conference - competing among 5 companies for the grand prize and winning $25,000 as a finalist of the 2023 MedTech Innovator Global Competition. IFPx was selected as a finalist among a global search that started with more than 1000 companies considered. IFPx pitched alongside Fingy3D, Neurava, Newrotex, and the Grand Prize Winner StrokeDx.

IFPx was featured in the September 29th episode of Device Talks, hosted by Tom Salemi and Kayleen Brown. This episode was entirely to the 10 Finalists of MedTech Innovator’s Pitch Competitions. Thanks to Tom Salemi for a great interview with our CEO, Amanda French, and for the opportunity to be featured!

MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced the finalists from its 61-company 2023 U.S. Accelerator Cohort. IFPx was named as one of the top 5 finalists for the grand prize.

IFPx presented as part of the Innovator Showcase at the WSGR Medical Device Digital Health Conference in June in San Francisco. The presentation was offered as part of IFPx’s participation in the 2023 MedTech Innovator Accelerator.

Our partners at The University of Sheffield presented some of the recent scientific work at the June 2023 British Cardiovascular Society's Annual conference, and were honored to have the research abstract published in Heart BMJ's online journal as well.

MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced the 2023 Accelerator Cohort. After a competitive selection process, 61 companies were chosen to participate in the MedTech Innovator’s flagship four-month MedTech Accelerator program.

IFPx delivered a featured presentation on the main stage at EuroPCR Innovator’s Day 2023.

We had a great conversation with Douglas Mann about our journey so far at IFPx - including what inspired the invention, our progress so far, and what the future has in store. Check out our episode on the JACC BTS Podcast to hear more!

IFPx published it’s first paper in JACC BTS, highlighting the pioneering scientific and technological development that the team has achieved to sense interstitial fluid pressure and show the correlation with key hemodynamic parameters.

IFPx is honored to have won both the Shark Tank and Poster Abstract competition at THT 2023.

The NXT IFPx heart failure sensor and digital health platform won the LaunchPad SBDC and Octane Capital & Growth Portfolio Company Presentations.

Stan Rowe, Co-Founder & CEO of NXT Medical, presented portfolio updates, including those for IFPx, at the LSI USA ‘22 Emerging Medtech Summit.